Neoregen Biotech

Neoregen Biotech is a South Korea-based biotechnology company focused on developing advanced intracellular delivery platforms, including next-generation peptide and lipid nanoparticle technologies for nucleic acid and macromolecule therapeutics. The company's proprietary NICT platform enables safe, targeted, and highly efficient delivery of macromolecular payloads across cell membranes and through endosomal barriers, showing promise in preclinical models for gene and cell therapy, especially for circular RNA and plasmid DNA vectors[2][3]. Neoregen partners with Circio for circRNA therapeutics and with A Biotech for lipid nanoparticle (LNP) technology[1][2]. The company also develops skin and cell delivery technologies for cosmetic applications[5].